Bioengineering the liver: scale-up and cool chain delivery of the liver cell biomass for clinical targeting in a bioartificial liver support system.
about
Evaluation of encapsulated liver cell spheroids in a fluidised-bed bioartificial liver for treatment of ischaemic acute liver failure in pigs in a translational settingImpact of Storage at -80°C on Encapsulated Liver Spheroids After Liquid Nitrogen StorageSpatial considerations during cryopreservation of a large volume sampleHepatic metabolism: a key component of herbal drugs research.Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications.Reversible immortalization of human hepatocytes mediated by retroviral transfer and site-specific recombination.Review: bioreactor design towards generation of relevant engineered tissues: focus on clinical translation.Generation and manipulation of hydrogel microcapsules by droplet-based microfluidics for mammalian cell culture.Cryopreservation and re-culture of a 2.3 litre biomass for use in a bioartificial liver devicePreservation and stability of cell therapy products: recommendations from an expert workshop.A scale down process for the development of large volume cryopreservation.Efficient One-Step Production of Microencapsulated Hepatocyte Spheroids with Enhanced Functions.Freestanding stacked mesh-like hydrogel sheets enable the creation of complex macroscale cellular scaffolds.GMP cryopreservation of large volumes of cells for regenerative medicine: active control of the freezing process.A clinical-scale BioArtificial Liver, developed for GMP, improved clinical parameters of liver function in porcine liver failure.Role of Bioreactor Technology in Tissue Engineering for Clinical Use and Therapeutic Target Design.
P2860
Q27300507-39C1FA4F-00B2-4F8E-8DC3-C7CD0D589DDBQ28828277-F117110C-8626-4B60-8458-CCD6F26D43CBQ37130466-329E2D7A-027D-4331-A44D-B1E9C535A08EQ38258151-87EA0290-5F62-4FAE-999B-07D8C782E8CFQ38264625-11FD3A61-3445-4D60-A868-7C9B0E57C006Q38950898-3EC5726A-7FCC-49CD-AF2B-FC11A81EF446Q39218394-CBBA91D7-C9B7-4416-A25E-210E47EF233CQ39310030-8FD9933A-DCBC-4525-A8B1-333FCC2E60CEQ41524074-A869330C-E370-4E98-9474-6DEEC97ABCCBQ41596650-0FA8FF75-47EA-425D-ACD7-582C27EB894EQ41953191-95CCE6DC-54DE-404D-AB45-D09804E83897Q42360674-F7BD4134-6821-45CB-AB65-13A655B29762Q42817435-99529EF8-A081-4124-B64B-9E893882F543Q42858136-FEA399D2-6048-4DB7-8AE0-4E2B725E12F5Q45978445-21B712E5-D02E-4406-9F57-C8F7675448EEQ52716712-FEFCB3F7-337C-4887-94CF-9E9C036E9AAE
P2860
Bioengineering the liver: scale-up and cool chain delivery of the liver cell biomass for clinical targeting in a bioartificial liver support system.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Bioengineering the liver: scal ...... tificial liver support system.
@ast
Bioengineering the liver: scal ...... tificial liver support system.
@en
type
label
Bioengineering the liver: scal ...... tificial liver support system.
@ast
Bioengineering the liver: scal ...... tificial liver support system.
@en
prefLabel
Bioengineering the liver: scal ...... tificial liver support system.
@ast
Bioengineering the liver: scal ...... tificial liver support system.
@en
P2093
P2860
P356
P1476
Bioengineering the liver: scal ...... rtificial liver support system
@en
P2093
Aude Gautier
Barry Fuller
Clare Selden
Humphrey Hodgson
Ian Llewellyn
Isobel Massie
James Bundy
Marcin Lubowiecki
Mike Hoare
P2860
P356
10.1089/BIORES.2012.0286
P577
2013-02-01T00:00:00Z